Transcriptome-based chemical screens identify CDK8 as a common barrier in multiple cell reprogramming systems

Cell Rep. 2023 Jun 27;42(6):112566. doi: 10.1016/j.celrep.2023.112566. Epub 2023 May 24.

Abstract

Fibroblasts can be chemically induced to pluripotent stem cells (CiPSCs) through an extraembryonic endoderm (XEN)-like state or directly converted into other differentiated cell lineages. However, the mechanisms underlying chemically induced cell-fate reprogramming remain unclear. Here, a transcriptome-based screen of biologically active compounds uncovered that CDK8 inhibition was essential to enable chemically induced reprogramming from fibroblasts into XEN-like cells, then CiPSCs. RNA-sequencing analysis showed that CDK8 inhibition downregulated proinflammatory pathways that suppress chemical reprogramming and facilitated the induction of a multi-lineage priming state, indicating the establishment of plasticity in fibroblasts. CDK8 inhibition also resulted in a chromatin accessibility profile like that under initial chemical reprogramming. Moreover, CDK8 inhibition greatly promoted reprogramming of mouse fibroblasts into hepatocyte-like cells and induction of human fibroblasts into adipocytes. These collective findings thus highlight CDK8 as a general molecular barrier in multiple cell reprogramming processes, and as a common target for inducing plasticity and cell fate conversion.

Keywords: CDK8; CP: Stem cell research; cell reprogramming; molecular barrier.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Differentiation
  • Cellular Reprogramming / genetics
  • Cyclin-Dependent Kinase 8* / genetics
  • Cyclin-Dependent Kinase 8* / metabolism
  • Fibroblasts / metabolism
  • Humans
  • Induced Pluripotent Stem Cells* / metabolism
  • Mice
  • Pluripotent Stem Cells* / metabolism
  • Transcriptome / genetics

Substances

  • CDK8 protein, human
  • Cyclin-Dependent Kinase 8